KLBF — A IDR10 bn investment for modern wound care products

KLBF — A IDR10 bn investment for modern wound care products Kalbe Farma (KLBF) has introduced around 20 types of modern wound care products to accelerate the healing process, solidifying its position as a pioneer in Indonesia's healthcare sector. Most of these products are imported from UK-based Smith & Nephew, with an annual investment of IDR10 bn. KLBF also plans to launch a new product called negative pressure wound therapy in 2Q25, which will be accessible for home use. Note that, in 1H24, KLBF’s net profit increased by 18.42% yoy to IDR1.80 tn. (Source : Kontan)